UCSF

ZINC00538152

Substance Information

In ZINC since Heavy atoms Benign functionality
September 26th, 2005 29 Yes

Other Names:

(+-)-2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1); 2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1); Atarax P; Bobsule

(E)-1,4,5,6-Tetrahydro-1-methyl-2-(2-(2-thienyl)vinyl)pyrimidine 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1); 2-Naphthalenecarboxylic acid, 4,4'-methylenebis(3-hydroxy), compd. with (E)-1,4,5,6-tetrahydro-1-methyl-2-(2-(2-thienyl)ethenyl)pyrimidine (1

1-(5-Hexamethyleneimino-2,4-pentadienylidene)hexamethyleniminium pamoate dihydrate; 1H-Azepinium, hexahydro-1-(5-1H-hexahydroazepino-2,4-pentadienylidene)-, pamoate, dihydrate; LS-22909

1-Piperazinepropanol, 4-(10,11-dihydro-8-(methylthio)dibenzo(b,f)thiepin-10-yl)-, 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylate), hydrate (1:1:1); 8-Methylthio-10-(4-(3-hydroxypropyl)piperazino)-10,11-dihydrodibenzo(b,f)thiepin embonate H2O; LS-113

10075-24-8; D08071; Imipramine embonate; Tofranil-pm (TN)

10246-75-0; CPD001370751; SAM002554902; Vistaril Pamoate

130-85-8; Pamoic acid; nsc30188

221373-18-8; D06623; Olanzapine pamoate (USAN); Olanzapine pamoate monohydrate

22204-24-6; C07389; Pyrantel pamoate

4,4'-Methylen-bis-(3-hydroxy-2-naphthoesaeure); 4,4'-Methylenebis(3-hydroxy-2-naphthoic acid); Embonic acid; Pamosaeure

4,4'-Methylenebis(3-hydroxy-2-naphthoic acid)

4,4'-Methylenebis(3-hydroxy-2-naphthoic acid) with tris-(p-aminophenyl)carbonium salt (1:2); 4,4'-Methylenebis(3-hydroxy-2-naphthoic acid) with tris-(p-aminophenyl)methylium salt (1:2); LS-91415; Methylium, tris(4-aminophenyl)-, 4,4'-methylenebis(3-hydrox

609-78-9; Cycloguanil embonate (INN); Cycloguanil pamoate (USAN); D02387

CI-1021

CP-14445

CP-14445-16

CPD001370751; Hydroxyzine pamoate; SAM002554902; Vistaril Pamoate

Disodium 4,4'-methylenebis(3-hydroxy-2-naphthoate)

DNC000426

Embonic acid

Embonic acid, Pamoic acid

HYDROXYZINE PAMOATE

Hydroxyzyne pamoate

Imipramine Pamoate (FDA)

LS-116798

LS-142319

LS-29425

MFCD00004079

MFCD00036183

MFCD00065060

MFCD00072037

MFCD02668695

MFCD02685142

MFCD19105662

MFCD25901662

NEMEX

Olanzapine Pamoate

Olanzapine Pamoate Monohydrate

Oxantel embonate

OXANTEL PAMOATE

Pamoic acid disodium salt

Pamoic acid, 98+%

Pamoic acid, 99%

pyrante

Pyrantel

Pyrantel pamoate

Pyrimidine,1,4,5,6-tetrahydro-1-methyl-2-[(1E)-2-(2-thienyl)ethenyl]-

Vistaril

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 5.52 10.73 -108.65 2 6 -2 121 386.359 4
Hi High (pH 8-9.5) 4.07 8.18 -2.17 0 0 0 0 180.316 1

Vendor Notes

Note Type Comments Provided By
Purity 95% Fluorochem
Mp [°C] >300 Acros Organics
Melting_Point >300? Alfa-Aesar
Melting_Point >300° Alfa-Aesar
Therapy anthelmintic SMDC Pharmakon
therap anxiolytic, antihistaminic MicroSource Spectrum
Patent Database Links EP1078925; EP1598346; EP1829529; EP1958615; US2001009923; US2003199582; US2004029963; US2005037067; US2007213257; US2008214554; US2008293695; US2008293728; WO2006027705; WO2007095156; WO2008144399 ChEBI
Indications GPR35 agonist KeyOrganics Bioactives
H phrase H315: Causes skin irritation; H319: Causes serious eye irritation; H335: May cause respiratory irritation Acros Organics
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : H-3432; NCC_SUPPLIER_SAMPLE_COMMENTS : YELLOW-GREEN POWDER; 1 pamoate NIH Clinical Collection via PubChem
P phrase P280: Wear protective gloves/protective clothing/eye protection/face protection; P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing Acros Organics
R phrase R36/37/38: Irritating to eyes, respiratory system and skin. Acros Organics
S phrase S24/25: Avoid contact with skin and eyes. Acros Organics
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: H-3432; SALT: 1 pamoate; SUPPLIER_COMMENTS: YELLOW-GREEN POWDER NIH Clinical Collection via PubChem
Indications schizophrenia, bipolar disorder KeyOrganics Bioactives
Patent Database Links US2005187267; US2007185018; WO2005077925; WO2005105096; WO2007112581; WO2008128647 ChEBI
Hazard XI: Irritant Acros Organics

Activity (Go SEA)

Analogs ( Draw Identity 99% 90% 80% 70% )